Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain Inhibitors. (2021)
Attributed to:
Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acsmedchemlett.1c00294
PubMed Identifier: 34413961
Publication URI: http://europepmc.org/abstract/MED/34413961
Type: Journal Article/Review
Volume: 12
Parent Publication: ACS medicinal chemistry letters
Issue: 8
ISSN: 1948-5875